J. Neugarten et al., Estradiol suppresses mesangial cell type I collagen synthesis via activation of the MAP kinase cascade, AM J P-REN, 277(6), 1999, pp. F875-F881
We have previously shown that estradiol suppresses the synthesis of type I
collagen by murine mesangial cells grown in the presence of serum via activ
ation of the transcription factor activator protein-1 (AP-1). We hypothesiz
ed that estradiol upregulates AP-1 via activation of the mitogen-activated
protein (MAP) kinase cascade, a signal transduction pathway that regulates
AP-1 activity. Estradiol (10(-10) to 10(-7) M) upregulated the MAP kinase p
athway in murine mesangial cells grown in the presence of serum in a dose-d
ependent manner. Activation was evident by 1 min, peaked at 10 min, and was
completely dissipated by 2 h. In contrast, estradiol had no significant ef
fect on total (phosphorylated + unphosphorylated) p44 extracellular signal-
related protein kinase (ERK) or p42 ERK. Nuclear extracts isolated from mes
angial cells treated with estradiol showed increased binding to a consensus
sequence AP-1 binding oligonucleotide in gel shift assays. In contrast, nu
clear extracts from cells exposed to PD-98059, a highly selective inhibitor
of MAP kinase-ERK kinase 1 (MEK1) and MEK2, showed reduced binding. In add
ition, PD-98059 antagonizes the enhanced binding induced by estradiol. Estr
adiol (10(-9) M) suppressed mesangial cell type I collagen synthesis (37.8
+/- 2.4%, expressed as a percentage of control values, P < 0.001 vs. contro
l). In contrast, PD-98059 increased type I collagen synthesis (344.6 +/- 98
.8, P < 0.01) and reversed the suppression of type I collagen synthesis ind
uced by estradiol. The effects of estradiol, PD-98059, and PD-98059 plus es
tradiol on type I collagen protein synthesis were closely paralleled by the
ir effects on steady-state levels of mRNA for the alpha(1) chain of type I
collagen. These data suggest that estradiol suppresses type I collagen synt
hesis via upregulation of the MAP kinase cascade, leading to stimulation of
AP-1 activity.